AlphaStocks
6.4
Consider Buy

Agilent Technologies, Inc. (A)

As of Sep 20, 2026, Agilent Technologies, Inc. (A) scores 6.4/10 on AlphaStocks' five-model composite, #33 of 168 Health Care stocks. At $156, A trades 28% above its model fair value of $122.

Health Care / Life Sciences Tools & Services

S&P 500

$156.46

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#33out of 168 in Health Care

Is AGILENT TECHNOLOGIES, INC. a Good Investment in 2026?

AGILENT TECHNOLOGIES, INC. (A) scores 6.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates AGILENT TECHNOLOGIES, INC. as Attractive (5/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. AGILENT TECHNOLOGIES, INC. currently trades 28% above its estimated fair value of $122. AGILENT TECHNOLOGIES, INC. ranks #33 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E34.2ROE19.9Market Cap44BDiv Yield0.7

Estimated Fair Value

$122.1928% above

Trading above estimated fair value. Eps growth of 3% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

PEG 4.7 · Stalwart

Greenblatt

Neutral

Earnings yield 4.4% · ROC 42%

Frequently Asked Questions

Is AGILENT TECHNOLOGIES, INC. (A) a good investment?
As of Sep 20, 2026, Agilent Technologies, Inc. (A) scores 6.4/10 on AlphaStocks' five-model composite, #33 of 168 Health Care stocks. At $156, A trades 28% above its model fair value of $122. That is a middle-of-the-pack score with no strong signal either way.
What is AGILENT TECHNOLOGIES, INC.'s Piotroski F-Score?
AGILENT TECHNOLOGIES, INC.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is A overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $122, A appears overvalued. The stock currently trades 28% above its estimated fair value. Trading above estimated fair value. Eps growth of 3% may not justify the premium.
How does A compare to other Health Care stocks?
AGILENT TECHNOLOGIES, INC. ranks #33 out of 168 stocks in the Health Care sector, placing it in the top 20% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about A?
AlphaStocks evaluates A using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 6.4/10.

Similar Stocks

BIOILMNAZTA

Compare A with

A vs BIOA vs ILMNA vs AZTA

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer